Trial Profile
A Pilot Study: Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 05 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Jul 2013 New trial record